Publication|Articles|May 26, 2024
Abstracts for the 2024 CMSC Annual Meeting Are Now Live!
Author(s)NeurologyLive® Staff
The 38th CMSC Annual Meeting is set to be held May 29-June 1, 2024, in Nashville, Tennessee. The International Journal of MS Care has published the abstracts.
Advertisement
The International Journal of MS Care, the official journal of the Consortium of Multiple Sclerosis Centers (CMSC), has published the full abstracts for the 38th Annual Meeting, set to be held May 29-June 1, 2024, in Nashville, Tennessee.
These abstracts include platform, poster, and Whitaker Research Track presentations. In the spirit of the age, a limited number of this supplement will be printed and available at the meeting and a digital version, including late-breaking abstracts, will be available to all on the IJMSC website at IJMSC.org.
The categories to be highlighted with the 2024 abstracts include:
- Diagnosis and Prognosis
- Basic Science
- Mental Health and Psychosocial Issues
- Comprehensive Clinical Care – The Team Approach
- Disease Modification and its Outcomes
- Epidemiology, Genetics, and Epigenetics
- Neuroimaging and Neurophysiology
- Programs that Support Quality of Life
- Rehabilitation Research and Strategies
- Symptom Management
- Advances in Technology
- Patient Reported Outcomes
- Programs and Methods of Care
- Case Reports/Case Series
The CMSC's Annual Meeting will host several thousand physicians, clinicians, nurses, physician assistants, rehabilitation specialists, and more. This year's meeting will also include 9 concurrent educational sessions each day, satellite symposia, and supporter showcases, with more than 70 exhibitors in a sprawling exhibit hall and many networking opportunities for attendees. Additionally, attending healthcare professionals can earn up to 26 continuing education credits for the meeting.
To register for the CMSC annual meeting, please visit the registration page .
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Expanding the Alzheimer Drug Development Pipeline
2
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
3
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
4
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
5